<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02261909</url>
  </required_header>
  <id_info>
    <org_study_id>1</org_study_id>
    <nct_id>NCT02261909</nct_id>
  </id_info>
  <brief_title>New Prognostic Kidney Function Markers in Emergency Patients New Markers of Kidney Function in ED Patients</brief_title>
  <official_title>New Prognostic Kidney Function Markers in Emergency Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Krankenhaus Barmherzige Brüder, Regensburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Astute Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Krankenhaus Barmherzige Brüder, Regensburg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      NephroCheck is measuring the concentration of a certain protein combination in the urine of
      patients. In elevated values there is a probability of renal failure (already proven in
      intensive care patients). The investigators would like to investigate whether the
      investigators can predict renal failure in patients receiving contrast enhanced CT's in the
      emergency department. That would lead to an earlier nephrologist consult in those patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of contrast agents can - especially in already in impaired renal function - lead to a
      decline in real function. The contrast enhanced CT is especially in emergency patients an
      important diagnostic tool for example in the detection of pulmonary embolism or mesenteric
      ischemia. Creatinine has been used as a marker for real function so far. But the
      investigators all know that creatinine is not a perfect marker especially as it is influenced
      by age, sex, weight and muscle mass. Especially in the diagnosis of acute renal failure
      creatinine does not allow and recent change in the kidney function.

      This prospective, unicentric study should therefore investigate two new markers in emergency
      patients who need an emergency contrast enhanced CT to early predict pending kidney function
      decline.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Renal function</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 7 days</time_frame>
    <description>renal function at discharge from hospital (creatinine and BUN measured at day of discharge)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Requirement for dialysis</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 7 days</time_frame>
    <description>dialysis required throughout hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Admission to ICU</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 7 days</time_frame>
    <description>admission to ICU required throughout hospital stay</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Acute Kidney Injury</condition>
  <condition>Contrast Media</condition>
  <arm_group>
    <arm_group_label>normal creatinine</arm_group_label>
    <description>pts receiving an iv-contrast enhanced CT with normal baseline renal function</description>
  </arm_group>
  <arm_group>
    <arm_group_label>elevated creatinine</arm_group_label>
    <description>pts receiving an iv-contrast enhanced CT with abnormal baseline renal function</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in the in emergency department who have the indication for contrast enhanced CT
        and a predicted hospital admission time of 48 hours or longer.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients in the emergency department who have the indication for contrast enhanced CT
             and a predicted hospital admission time of 48 hours or longer.

        Exclusion Criteria:

          -  children, pregnant women

          -  dialysis

          -  patients with kidney transplants

          -  patients on steroids or further immunocompromised
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Braess, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Krankenhaus Barmherzige Brüder</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Felix Rockmann, MD</last_name>
    <phone>+49 941 369</phone>
    <phone_ext>2341</phone_ext>
    <email>felix.rockmann@barmherzige-regensburg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tanja Brünnler, MD, PhD</last_name>
    <phone>+49 941 369</phone>
    <phone_ext>2341</phone_ext>
    <email>tanja.bruennler@barmherzige-regensburg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Krankenhaus Barmherzige Brueder</name>
      <address>
        <city>Regensburg</city>
        <state>Bavaria</state>
        <zip>93049</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felix Rockmann, MD</last_name>
      <phone>+49941369</phone>
      <phone_ext>2341</phone_ext>
      <email>felix.rockmann@barmherzige-regensburg.de</email>
    </contact>
    <contact_backup>
      <last_name>Tanja Brünnler, MD</last_name>
      <phone>+49941369</phone>
      <phone_ext>2341</phone_ext>
      <email>tanja.bruennler@barmherzige-regensburg.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Meersch M, Schmidt C, Van Aken H, Martens S, Rossaint J, Singbartl K, Görlich D, Kellum JA, Zarbock A. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One. 2014 Mar 27;9(3):e93460. doi: 10.1371/journal.pone.0093460. eCollection 2014.</citation>
    <PMID>24675717</PMID>
  </reference>
  <reference>
    <citation>Olden M, Corre T, Hayward C, Toniolo D, Ulivi S, Gasparini P, Pistis G, Hwang SJ, Bergmann S, Campbell H, Cocca M, Gandin I, Girotto G, Glaudemans B, Hastie ND, Loffing J, Polasek O, Rampoldi L, Rudan I, Sala C, Traglia M, Vollenweider P, Vuckovic D, Youhanna S, Weber J, Wright AF, Kutalik Z, Bochud M, Fox CS, Devuyst O. Common variants in UMOD associate with urinary uromodulin levels: a meta-analysis. J Am Soc Nephrol. 2014 Aug;25(8):1869-82. doi: 10.1681/ASN.2013070781. Epub 2014 Feb 27.</citation>
    <PMID>24578125</PMID>
  </reference>
  <reference>
    <citation>Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013 Feb 4;17(1):204. doi: 10.1186/cc11454. Review.</citation>
    <PMID>23394211</PMID>
  </reference>
  <reference>
    <citation>Lameire N, Kellum JA; KDIGO AKI Guideline Work Group. Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2). Crit Care. 2013 Feb 4;17(1):205. doi: 10.1186/cc11455. Review.</citation>
    <PMID>23394215</PMID>
  </reference>
  <reference>
    <citation>Risch L, Lhotta K, Meier D, Medina-Escobar P, Nydegger UE, Risch M. The serum uromodulin level is associated with kidney function. Clin Chem Lab Med. 2014 Dec;52(12):1755-61. doi: 10.1515/cclm-2014-0505.</citation>
    <PMID>24933630</PMID>
  </reference>
  <reference>
    <citation>Bihorac A, Chawla LS, Shaw AD, Al-Khafaji A, Davison DL, Demuth GE, Fitzgerald R, Gong MN, Graham DD, Gunnerson K, Heung M, Jortani S, Kleerup E, Koyner JL, Krell K, Letourneau J, Lissauer M, Miner J, Nguyen HB, Ortega LM, Self WH, Sellman R, Shi J, Straseski J, Szalados JE, Wilber ST, Walker MG, Wilson J, Wunderink R, Zimmerman J, Kellum JA. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med. 2014 Apr 15;189(8):932-9. doi: 10.1164/rccm.201401-0077OC.</citation>
    <PMID>24559465</PMID>
  </reference>
  <reference>
    <citation>Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, Davison DL, Feldkamp T, Forni LG, Gong MN, Gunnerson KJ, Haase M, Hackett J, Honore PM, Hoste EA, Joannes-Boyau O, Joannidis M, Kim P, Koyner JL, Laskowitz DT, Lissauer ME, Marx G, McCullough PA, Mullaney S, Ostermann M, Rimmelé T, Shapiro NI, Shaw AD, Shi J, Sprague AM, Vincent JL, Vinsonneau C, Wagner L, Walker MG, Wilkerson RG, Zacharowski K, Kellum JA. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013 Feb 6;17(1):R25. doi: 10.1186/cc12503.</citation>
    <PMID>23388612</PMID>
  </reference>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 3, 2014</study_first_submitted>
  <study_first_submitted_qc>October 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2014</study_first_posted>
  <last_update_submitted>August 14, 2015</last_update_submitted>
  <last_update_submitted_qc>August 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Emergency Medicine</keyword>
  <keyword>diagnosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

